Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.030
-0.030 (-2.83%)
Jun 6, 2025, 4:08 PM HKT
87.27%
Market Cap 9.42B
Revenue (ttm) 2.02B
Net Income (ttm) -230.57M
Shares Out 9.15B
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend 0.02 (1.98%)
Ex-Dividend Date Sep 27, 2024
Volume 101,033,000
Average Volume 159,938,382
Open 1.060
Previous Close 1.060
Day's Range 1.030 - 1.060
52-Week Range 0.495 - 1.120
Beta 0.69
RSI 71.42
Earnings Date Aug 29, 2025

About HKG:0460

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China. The company operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. It offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthetics comprehensive solu... [Read more]

Sector Healthcare
Founded 2001
Employees 2,667
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0460
Full Company Profile

Financial Performance

In 2024, HKG:0460's revenue was 1.90 billion, an increase of 2.18% compared to the previous year's 1.86 billion. Losses were -216.66 million, 301.1% more than in 2023.

Financial numbers in CNY Financial Statements

News

There is no news available yet.